The burden of type 2 diabetes in Australia during the period 1990–2019: Findings from the global burden of disease study

Islam, Sheikh Mohammed Shariful; Siopis, George; Sood, Surbhi; Uddin, Riaz; Porter, Judi; Dunstan, David W.; Colagiuri, Stephen; Zimmet, Paul; George, Elena S.; Maddison, Ralph

doi:10.1016/j.diabres.2023.110631

Cited by 6 publications

(3 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…16 Likewise, the prevalence of the MS in adults has reached rates up to 12-31%, which largely depends on the disease definition and the study population. 17 Similarly, the prevalence of T2D, a consequence of insulin resistance in the MS, dramatically increased in many parts of the world, for example, Australia, during the last two decades, 18 and today 1 in 10 individuals are living with diabetes. 2 The parallel rise of IBD and metabolic disorders (with the MS being the most pronounced phenotype) raises the possibility that these disorders originate from similar culprits in Westernised societies, such as a Western lifestyle with related dietary habits and microbial rarefication.…”

Section: Epidemiologymentioning

confidence: 99%

“… 16 Likewise, the prevalence of the MS in adults has reached rates up to 12–31%, which largely depends on the disease definition and the study population. 17 Similarly, the prevalence of T2D, a consequence of insulin resistance in the MS, dramatically increased in many parts of the world, for example, Australia, during the last two decades, 18 and today 1 in 10 individuals are living with diabetes. 2…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Heavy arch: from inflammatory bowel diseases to metabolic disorders

Adolph,

Meyer,

Jukic

et al. 2024

Gut

View full text Add to dashboard Cite

BackgroundMetabolic disorders and inflammatory bowel diseases (IBD) have captured the globe during Westernisation of lifestyle and related dietary habits over the last decades. Both disease entities are characterised by complex and heterogeneous clinical spectra linked to distinct symptoms and organ systems which, on a first glimpse, do not have many commonalities in clinical practice. However, experimental studies indicate a common backbone of inflammatory mechanisms in metabolic diseases and gut inflammation, and emerging clinical evidence suggests an intricate interplay between metabolic disorders and IBD.ObjectiveWe depict parallels of IBD and metabolic diseases, easily overlooked in clinical routine.DesignWe provide an overview of the recent literature and discuss implications of metabolic morbidity in patients with IBD for researchers, clinicians and healthcare providers.ConclusionThe Western lifestyle and diet and related gut microbial perturbation serve as a fuel for metabolic inflammation in and beyond the gut. Metabolic disorders and the metabolic syndrome increasingly affect patients with IBD, with an expected negative impact for both disease entities and risk for complications. This concept implies that tackling the obesity pandemic exerts beneficial effects beyond metabolic health.

show abstract

Section: Epidemiologymentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Heavy arch: from inflammatory bowel diseases to metabolic disorders

Adolph,

Meyer,

Jukic

et al. 2024

Gut

View full text Add to dashboard Cite

show abstract

“…A critical imperative for Australia is addressing the health vulnerabilities and requirements of disadvantaged, Indigenous Australians and individuals affected by non-communicable diseases (NCDs). 3 , 4 , 5 However, many NCDs and their risk factors in Australia remain undiagnosed and uncontrolled and are often managed in isolation by general practitioners, specialists, and allied health professionals. The findings by Luo et al.…”

mentioning

confidence: 99%